Arca
Skip to content
Tools
Tools

ITGAV, ITGB3: Integrin alpha-V/beta-3

Complex in Homo sapiens that 6 drugs act on.

  • Drugs that act on it: 6
  • Approved: 1
  • In phases 1 to 3: 5
  • Sponsors: 4

Who is on it, and how far along

Every drug ChEMBL records acting on ITGAV, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Antibody 4
  • Protein or peptide 2

Approved1

  • Abciximab

Phase 31

  • Cilengitide

Phase 24

  • Abituzumab
  • ATN-161
  • Etaracizumab
  • Intetumumab

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 4 of 6 act as: Integrin alpha-V/beta-3 antagonist; the rest name their own mechanism.
    AbciximabApprovedJohnson & JohnsonAntibodyInhibitorIntegrin alpha-V/beta-3 inhibitor0
    CilengitidePhase 3—Protein or peptideAntagonist0
    AbituzumabPhase 2Merck KGaA, Darmstadt, GermanyAntibodyInhibitorIntegrin alpha-V/beta-3 inhibitor0
    ATN-161Phase 2AttenuonProtein or peptideAntagonist0
    EtaracizumabPhase 2MedImmune LLCAntibodyAntagonist0
    IntetumumabPhase 2Johnson & JohnsonAntibodyAntagonist0

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1907598, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.